- call +1-201-465-4211
- email sales@mrinsights.biz
A biobank can be defined as an organized and programed storage of biological materials and corresponding data that can be used in healthcare research. The biological samples vital for medical innovation include tissue, body fluids (such as serum, blood, urine, or fluids from punctures), related derivatives (RNA, DNA, or proteins), and cells.
Scope of the Report:
This report studies the Biobanks market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biobanks market by product type and applications/end industries.
As biobanks help in providing personalized medications and minimizing drug side effects, thereby improving the overall health of patients suffering from various diseases, the demand for biobanks will augment worldwide. Some of the key factors driving the market for biobanks are advancement in drug discovery, rising prevalence of chronic disorders such as cancer, respiratory disorders, and cardiovascular diseases, increasing healthcare expenditure, and several government initiatives supporting the development of biobanks. Another growth driver of the global biobanks market is the gradual propagation of awareness about biobanks and their significance.
The global Biobanks market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biobanks.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Thermo Fisher Scientific (US)
Tecan Group (Switzerland)
Qiagen (Germany)
Hamilton (US)
Brooks Automation (US)
TTP Labtech (UK)
VWR (US)
Promega (US)
Worthington Industries (US)
Chart Industries (US)
Becton Dickinson (US)
Merck (Germany)
Micronic (Netherlands)
LVL Technologies (Germany)
Panasonic Healthcare (Japan)
Greiner Bio One (Greiner Holding AG, Austria)
Biokryo (Germany)
Biobank (Norway)
Biorep Technologies (US)
Cell & Co Bioservices (France)
RUCDR infinite biologics (US)
Modul-Bio (France)
CSols (UK)
Ziath (UK)
LabVantage Solutions (US)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Biological Fluids
Human Waste Products
Market Segment by Applications, can be divided into
Regenerative Medicine
Life Science Research
Clinical Research
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biobanks Market Overview
1.1 Product Overview and Scope of Biobanks
1.2 Classification of Biobanks by Types
1.2.1 Global Biobanks Revenue Comparison by Types (2017-2023)
1.2.2 Global Biobanks Revenue Market Share by Types in 2017
1.2.3 Blood Products
1.2.4 Human Tissues
1.2.5 Nucleic Acids
1.2.6 Cell Lines
1.2.7 Biological Fluids
1.2.8 Human Waste Products
1.3 Global Biobanks Market by Application
1.3.1 Global Biobanks Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Regenerative Medicine
1.3.3 Life Science Research
1.3.4 Clinical Research
1.4 Global Biobanks Market by Regions
1.4.1 Global Biobanks Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biobanks Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biobanks Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biobanks Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biobanks Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biobanks Status and Prospect (2013-2023)
1.5 Global Market Size of Biobanks (2013-2023)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific (US)
2.1.1 Business Overview
2.1.2 Biobanks Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fisher Scientific (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.2 Tecan Group (Switzerland)
2.2.1 Business Overview
2.2.2 Biobanks Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Tecan Group (Switzerland) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.3 Qiagen (Germany)
2.3.1 Business Overview
2.3.2 Biobanks Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Qiagen (Germany) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.4 Hamilton (US)
2.4.1 Business Overview
2.4.2 Biobanks Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hamilton (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.5 Brooks Automation (US)
2.5.1 Business Overview
2.5.2 Biobanks Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Brooks Automation (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.6 TTP Labtech (UK)
2.6.1 Business Overview
2.6.2 Biobanks Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 TTP Labtech (UK) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.7 VWR (US)
2.7.1 Business Overview
2.7.2 Biobanks Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 VWR (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.8 Promega (US)
2.8.1 Business Overview
2.8.2 Biobanks Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Promega (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.9 Worthington Industries (US)
2.9.1 Business Overview
2.9.2 Biobanks Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Worthington Industries (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.10 Chart Industries (US)
2.10.1 Business Overview
2.10.2 Biobanks Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Chart Industries (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.11 Becton Dickinson (US)
2.11.1 Business Overview
2.11.2 Biobanks Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Becton Dickinson (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.12 Merck (Germany)
2.12.1 Business Overview
2.12.2 Biobanks Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck (Germany) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.13 Micronic (Netherlands)
2.13.1 Business Overview
2.13.2 Biobanks Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Micronic (Netherlands) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.14 LVL Technologies (Germany)
2.14.1 Business Overview
2.14.2 Biobanks Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 LVL Technologies (Germany) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.15 Panasonic Healthcare (Japan)
2.15.1 Business Overview
2.15.2 Biobanks Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Panasonic Healthcare (Japan) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.16 Greiner Bio One (Greiner Holding AG, Austria)
2.16.1 Business Overview
2.16.2 Biobanks Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Greiner Bio One (Greiner Holding AG, Austria) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.17 Biokryo (Germany)
2.17.1 Business Overview
2.17.2 Biobanks Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Biokryo (Germany) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.18 Biobank (Norway)
2.18.1 Business Overview
2.18.2 Biobanks Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Biobank (Norway) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.19 Biorep Technologies (US)
2.19.1 Business Overview
2.19.2 Biobanks Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Biorep Technologies (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.20 Cell & Co Bioservices (France)
2.20.1 Business Overview
2.20.2 Biobanks Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Cell & Co Bioservices (France) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.21 RUCDR infinite biologics (US)
2.21.1 Business Overview
2.2.2 Biobanks Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 RUCDR infinite biologics (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.22 Modul-Bio (France)
2.22.1 Business Overview
2.22.2 Biobanks Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Modul-Bio (France) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.23 CSols (UK)
2.23.1 Business Overview
2.23.2 Biobanks Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 CSols (UK) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.24 Ziath (UK)
2.24.1 Business Overview
2.24.2 Biobanks Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Ziath (UK) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
2.25 LabVantage Solutions (US)
2.25.1 Business Overview
2.25.2 Biobanks Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 LabVantage Solutions (US) Biobanks Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biobanks Market Competition, by Players
3.1 Global Biobanks Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biobanks Players Market Share
3.2.2 Top 10 Biobanks Players Market Share
3.3 Market Competition Trend
4 Global Biobanks Market Size by Regions
4.1 Global Biobanks Revenue and Market Share by Regions
4.2 North America Biobanks Revenue and Growth Rate (2013-2018)
4.3 Europe Biobanks Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biobanks Revenue and Growth Rate (2013-2018)
4.5 South America Biobanks Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biobanks Revenue and Growth Rate (2013-2018)
5 North America Biobanks Revenue by Countries
5.1 North America Biobanks Revenue by Countries (2013-2018)
5.2 USA Biobanks Revenue and Growth Rate (2013-2018)
5.3 Canada Biobanks Revenue and Growth Rate (2013-2018)
5.4 Mexico Biobanks Revenue and Growth Rate (2013-2018)
6 Europe Biobanks Revenue by Countries
6.1 Europe Biobanks Revenue by Countries (2013-2018)
6.2 Germany Biobanks Revenue and Growth Rate (2013-2018)
6.3 UK Biobanks Revenue and Growth Rate (2013-2018)
6.4 France Biobanks Revenue and Growth Rate (2013-2018)
6.5 Russia Biobanks Revenue and Growth Rate (2013-2018)
6.6 Italy Biobanks Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biobanks Revenue by Countries
7.1 Asia-Pacific Biobanks Revenue by Countries (2013-2018)
7.2 China Biobanks Revenue and Growth Rate (2013-2018)
7.3 Japan Biobanks Revenue and Growth Rate (2013-2018)
7.4 Korea Biobanks Revenue and Growth Rate (2013-2018)
7.5 India Biobanks Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biobanks Revenue and Growth Rate (2013-2018)
8 South America Biobanks Revenue by Countries
8.1 South America Biobanks Revenue by Countries (2013-2018)
8.2 Brazil Biobanks Revenue and Growth Rate (2013-2018)
8.3 Argentina Biobanks Revenue and Growth Rate (2013-2018)
8.4 Colombia Biobanks Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biobanks by Countries
9.1 Middle East and Africa Biobanks Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biobanks Revenue and Growth Rate (2013-2018)
9.3 UAE Biobanks Revenue and Growth Rate (2013-2018)
9.4 Egypt Biobanks Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biobanks Revenue and Growth Rate (2013-2018)
9.6 South Africa Biobanks Revenue and Growth Rate (2013-2018)
10 Global Biobanks Market Segment by Type
10.1 Global Biobanks Revenue and Market Share by Type (2013-2018)
10.2 Global Biobanks Market Forecast by Type (2018-2023)
10.3 Blood Products Revenue Growth Rate (2013-2023)
10.4 Human Tissues Revenue Growth Rate (2013-2023)
10.5 Nucleic Acids Revenue Growth Rate (2013-2023)
10.6 Cell Lines Revenue Growth Rate (2013-2023)
10.7 Biological Fluids Revenue Growth Rate (2013-2023)
10.8 Human Waste Products Revenue Growth Rate (2013-2023)
11 Global Biobanks Market Segment by Application
11.1 Global Biobanks Revenue Market Share by Application (2013-2018)
11.2 Biobanks Market Forecast by Application (2018-2023)
11.3 Regenerative Medicine Revenue Growth (2013-2018)
11.4 Life Science Research Revenue Growth (2013-2018)
11.5 Clinical Research Revenue Growth (2013-2018)
12 Global Biobanks Market Size Forecast (2018-2023)
12.1 Global Biobanks Market Size Forecast (2018-2023)
12.2 Global Biobanks Market Forecast by Regions (2018-2023)
12.3 North America Biobanks Revenue Market Forecast (2018-2023)
12.4 Europe Biobanks Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biobanks Revenue Market Forecast (2018-2023)
12.6 South America Biobanks Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biobanks Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biobanks Picture
Table Product Specifications of Biobanks
Table Global Biobanks and Revenue (Million USD) Market Split by Product Type
Figure Global Bio
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
